Century Therapeutics, Inc. (IPSC) Tops Q1 EPS by 96c

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q1 EPS of $0.89, $0.96 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $109.16 million versus the consensus estimate of $19.94 million.

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Noodles & Company (NDLS) files $100M mixed shelf
• ZeroStack (ZSTK) files for 54.61M share offering by selling stockholders